Acute respiratory failure in COVID-19: is it “typical” ARDS?
Abstract In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) was identified in Wuhan, China. The World Health Organization (WHO) declared this outbreak a significant threat to international health. COVID-19 is highly infectious and can lead to fatal comorbidities especially acute re...
Main Authors: | Xu Li, Xiaochun Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13054-020-02911-9 |
Similar Items
-
Acute Respiratory Distress Syndrome: A Literature Review and Current Updates
by: Ata Mahmoodpoor, et al.
Published: (2015-10-01) -
The impact of the new acute respiratory distress syndrome (ARDS) criteria on Berlin criteria ARDS patients: a multicenter cohort study
by: Lina Zhao, et al.
Published: (2023-11-01) -
Evaluation of Treatment with a single (400mg) versus double dose (800mg) of Tocilizumab in Acute Respiratory Distress Syndrome Associated with COVID-19Pneumonia
by: Mehmet Kabak, et al.
Published: (2022-01-01) -
Case Report: Survival of A Coronavirus Disease-2019 (Covid-19) Patient with Acute Respiratory Distress Syndrome (ARDS) in Dr. Soetomo Hospital, Surabaya, Indonesia
by: Soedarsono Soedarsono, et al.
Published: (2021-01-01) -
Testing oxygenated microbubbles via intraperitoneal and intrathoracic routes on a large pig model of LPS‐induced acute respiratory distress syndrome
by: Riaz Ur Rehman Mohammed, et al.
Published: (2022-09-01)